$14.22
0.120.85%
At close: May 8, 5:00 PM EST
$14.22
N/A
After Hours: May 8, 4:19 PM EST
Design Therapeutics Inc Earnings Estimates
DSGNNASDAQ
Design Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:DSGN
Design Therapeutics (DSGN) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.35 and quarterly revenue of N/A.
In the most recent quarter (Q1), Design Therapeutics reported EPS of $-0.29, beating estimates of $-0.34 by 0.15%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Design Therapeutics has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Design Therapeutics has averaged an EPS surprise of 0.14% and a revenue surprise of 0.00%.
Earnings Date
Aug 6
EPS Estimate
$-0.350
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Design Therapeutics Earnings History
Analyze the earnings history of Design Therapeutics using advanced sorting and filters.
Loading calendar...
Design Therapeutics (DSGN) Earnings Per Share
The chart below shows Design Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Design Therapeutics (DSGN) Revenue
The chart below shows Design Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?
Design Therapeutics (DSGN) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on April 28, 2026 for Q1.
What were the latest earnings per share (EPS) for Design Therapeutics (NASDAQ:DSGN)?
The Actual EPS was $-0.29, which beat the estimate of $-0.34.
What were Design Therapeutics’s (NASDAQ:DSGN) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
